152 related articles for article (PubMed ID: 37190296)
1. Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients-A Single-Center Analysis of 1294 Patients within the Last Decade.
Neumann CCM; Schneider F; Hilfenhaus G; Vecchione L; Felsenstein M; Ihlow J; Geisel D; Sander S; Pratschke J; Stintzing S; Keilholz U; Pelzer U
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190296
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
4. Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.
Chen T; Tang M; Xu X; Liang G; Xiang Z; Lu Y; Wang C; Shen W
J Clin Lab Anal; 2022 Dec; 36(12):e24772. PubMed ID: 36441595
[TBL] [Abstract][Full Text] [Related]
5. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer.
Huang Q; Diao P; Li CL; Peng Q; Xie T; Tan Y; Lang JY
Medicine (Baltimore); 2020 Jan; 99(4):e18607. PubMed ID: 31977852
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma.
Zhao X; Zhou Y; Liu B; Shen Y; Qian J; Zhang X; Zhao H
Med Sci Monit; 2023 Mar; 29():e939442. PubMed ID: 36992543
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.
Açıksarı G; Koçak M; Çağ Y; Altunal LN; Atıcı A; Çelik FB; Bölen F; Açıksarı K; Çalışkan M
Biomark Insights; 2021; 16():11772719211027022. PubMed ID: 34248354
[TBL] [Abstract][Full Text] [Related]
8. Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience.
Luo H; Ge H; Cui Y; Zhang J; Fan R; Zheng A; Zheng X; Sun Y
J Cancer; 2018; 9(1):182-188. PubMed ID: 29290784
[No Abstract] [Full Text] [Related]
9. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
Mandaliya H; Jones M; Oldmeadow C; Nordman II
Transl Lung Cancer Res; 2019 Dec; 8(6):886-894. PubMed ID: 32010567
[TBL] [Abstract][Full Text] [Related]
10. Does Preoperative Serum Neutrophil to Lymphocyte Ratio (NLR), Platelet to Lymphocyte Ratio (PLR), and Lymphocyte to Monocyte Ratio (LMR) Predict Prognosis Following Radical Surgery for Pancreatic Adenocarcinomas? Results of a Retrospective Study.
Gupta V; Chaudhari V; Shrikhande SV; Bhandare MS
J Gastrointest Cancer; 2022 Sep; 53(3):641-648. PubMed ID: 34406625
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Neutrophil:Lymphocyte and Platelet:Lymphocyte Ratios for 28-Day Mortality of Patients with AECOPD.
Luo Z; Zhang W; Chen L; Xu N
Int J Gen Med; 2021; 14():2839-2848. PubMed ID: 34211292
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment Inflammatory Indexes as Prognostic Predictors of Survival in Patients Suffering From Synovial Sarcoma.
Cheng Y; Mo F; Pu L; Li Q; Ma X
Front Oncol; 2019; 9():955. PubMed ID: 31608240
[No Abstract] [Full Text] [Related]
13. The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma.
Onoe S; Maeda A; Takayama Y; Fukami Y; Takahashi T; Uji M; Kaneoka Y
Med Princ Pract; 2019; 28(6):517-525. PubMed ID: 31104057
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma.
Li YJ; Yang X; Zhang WB; Yi C; Wang F; Li P
Cancer Manag Res; 2017; 9():443-451. PubMed ID: 29033609
[TBL] [Abstract][Full Text] [Related]
16. Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Tumor-Infiltrating Lymphocytes (TILs) in Left-Sided Colorectal Cancer Patients.
Gawiński C; Michalski W; Mróz A; Wyrwicz L
Biology (Basel); 2022 Feb; 11(3):. PubMed ID: 35336759
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer.
Adamkiewicz M; Bryniarski P; Kowalik M; Burzyński B; Rajwa P; Paradysz A
Front Oncol; 2021; 11():655000. PubMed ID: 33842371
[TBL] [Abstract][Full Text] [Related]
20. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
